Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00849251
What this trial is testing

Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
University of Washington 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04769895
What this trial is testing

MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients

Who this might be right for
Acute Graft Versus Host Disease in IntestineSteroid Refractory GVHD
MaaT Pharma 66
Not applicableUnknownNCT00416377
What this trial is testing

Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Children's Cancer and Leukaemia Group 353
Large-scale testing (Phase 3)Study completedNCT01460030
What this trial is testing

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

Who this might be right for
Parathyroid CarcinomaHypercalcemiaPrimary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Large-scale testing (Phase 3)Ended earlyNCT04378075
What this trial is testing

Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Who this might be right for
Mitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more
PTC Therapeutics 68
Not applicableUnknownNCT04833712
What this trial is testing

Stereotactic Radioablation for the Treatment of Refractory Atrial Fibrillation

Who this might be right for
Atrial FibrillationArrythmiaCardiovascular Diseases+1 more
National and Kapodistrian University of Athens 15
Very early researchUnknownNCT03661554
What this trial is testing

BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
The Pregene (ShenZhen) Biotechnology Company, Ltd. 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05801939
What this trial is testing

Cevostamab Following CAR T Cell Therapy for RRMM

Who this might be right for
Relapsed/Refractory Multiple Myeloma
University of Pennsylvania 30
Not applicableUnknownNCT02601677
What this trial is testing

Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder

Who this might be right for
Obsessive Compulsive Disorder
Tang-Du Hospital 10
Not applicableStudy completedNCT00710073
What this trial is testing

Sono-Electro-Magnetic Therapy for Refractory Chronic Pelvic Pain Syndrome

Who this might be right for
Chronic Pelvic Pain Syndrome
Insel Gruppe AG, University Hospital Bern 12
Early research (Phase 1)Not Yet RecruitingNCT07790575
What this trial is testing

Autoimmune Cytopenia Elimination by Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Cytopenia
Saurabh Dahiya 16
Large-scale testing (Phase 3)UnknownNCT05006469
What this trial is testing

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Who this might be right for
BendamustineMultiple Myeloma
Liao Aijun 10
Early research (Phase 1)Study completedNCT03207529
What this trial is testing

Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+15 more
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT03502629
What this trial is testing

Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226)

Who this might be right for
Peripheral T Cell Lymphoma
Genor Biopharma Co., Ltd. 86
Large-scale testing (Phase 3)UnknownNCT05177939
What this trial is testing

Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis

Who this might be right for
Autoimmune Encephalitis
Nihon Pharmaceutical Co., Ltd 40
Testing effectiveness (Phase 2)Looking for participantsNCT06538012
What this trial is testing

TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer

Who this might be right for
Lung CancerLung Cancer MetastaticLung Cancer, Non-small Cell+1 more
Essen Biotech 85
Very early researchUnknownNCT06067581
What this trial is testing

The Safety and Efficacy of SENL103 Autologous T Cell Injection

Who this might be right for
Multiple Myeloma
Hebei Senlang Biotechnology Inc., Ltd. 20
Not applicableLooking for participantsNCT07160322
What this trial is testing

Refractory Breathlessness in COPD

Who this might be right for
COPD
Seoul National University 730
Testing effectiveness (Phase 2)Looking for participantsNCT06235229
What this trial is testing

GC012F in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Gracell Biotechnologies (Shanghai) Co., Ltd. 110
Early research (Phase 1)Active Not RecruitingNCT03017131
What this trial is testing

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Roswell Park Cancer Institute 9
Next Page